| [1] |
Jia L, Quan M, Fu Y, et al. Dementia in China: Epidemiology, clinical management, and research advances[J]. Lancet Neurol, 2020, 19(1):81-92.
|
| [2] |
Jack CJ, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease[J]. Alzheimers Dement, 2018, 14(4):535-562.
|
| [3] |
Zhao Y, Tudorascu DL, Lopez OL, et al. Amyloid beta deposition and suspected non-alzheimer pathophysiology and cognitive decline patterns for 12 years in oldest old participants without dementia[J]. Jama Neurol, 2018, 75(1): 88-96.
|
| [4] |
Chen KL, Xu Y, Chu AQ, et al. Validation of the Chinese version of montreal cognitive assessment basic for screening mild cognitive impairment[J]. J Am Geriatr Soc, 2016, 64(12):e285-e290.
|
| [5] |
Pan FF, Wang Y, Huang L, et al. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment[J]. Aging Ment Health, 2022, 26(2):384-391.
|
| [6] |
Norton DJ, Parra MA, Sperling RA, et al. Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer's disease[J]. Alzheimers Res Ther, 2020, 12(1):99.
|
| [7] |
Parra MA, Calia C, Pattan V, et al. Memory markers in the continuum of the Alzheimer's clinical syndrome[J]. Alzheimers Res Ther, 2022, 14(1):142.
|
| [8] |
Loewenstein DA, Curiel RE, DeKosky S, et al. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment[J]. Neurology, 2018, 91(10):e976-e984.
|
| [9] |
Wang L, Zhu J, Wang Q, et al. Hormesis effects of sulfoxaflor on Aphis gossypii feeding, growth, reproduction behaviour and the related mechanisms[J]. Sci Total Environ, 2023, 872:162240.
|
| [10] |
Li Q, Sun X, Cui L, Zhong Y, et al. Alterations in metamemory capacity and neural correlates in a subtype of subjective cognitive decline[J]. Neuroimage Clin, 2022, 36:103255.
|
| [11] |
Gagliardi G, Houot M, Cacciamani F, et al. The meta-memory ratio: A new cohort-independent way to measure cognitive awareness in asymptomatic individuals at risk for Alzheimer's disease[J]. Alzheimers Res Ther, 2020, 12(1):57.
|
| [12] |
Gagliardi G, Kuppe M, Lois C, et al. Pathological correlates of impaired self-awareness of memory function in Alzheimer's disease[J]. Alzheimers Res Ther, 2021, 13(1):118.
|
| [13] |
Vannini P, Amariglio R, Hanseeuw B, et al. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease[J]. Neuropsychologia, 2017, 99:343-349.
|
| [14] |
Edmonds EC, Weigand AJ, Thomas KR, et al. Increasing inaccuracy of self-reported subjective cognitive complaints over 24 months in empirically derived subtypes of mild cognitive impairment[J]. J Int Neuropsychol Soc, 2018, 24(8):842-853.
|
| [15] |
Buegler M, Harms R, Balasa M, et al. Digital biomarker-based individualized prognosis for people at risk of dementia[J]. Alzheimers Dement (Amst), 2020, 12(1):e12073.
|
| [16] |
Hajjar I, Okafor M, Choi JD, et al. Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer's disease[J]. Alzheimers Dement (Amst), 2023, 15(1):e12393.
|
| [17] |
Ngoo QZ, Wan HW, Ab RA. Evaluation of retinal nerve fiber layer thickness, electroretinogram and visual evoked potential in patients with Alzheimer's disease[J]. J Ophthalmol, 2019, 2019:6248185.
|